Course Overview
Please note that there is no registration deadline, as this course is open enrollment, and there is currently no end date.
This course aims to provide knowledge and skills for patients on the topic of biosimilars, a class of biologic drugs or medical therapies that are highly similar to an existing originator medication that is off patent.
Biosimilars represent a rapidly growing area in pharmaceutical development, treatment options, and patient care that require an evidence-informed implementation approach.
As awareness and use of biosimilars increases globally, this course will provide information and guidance to support patient understanding of the effective and safe use of biosimilars in clinical settings.
The course will focus on enhancing knowledge and skills for patients and caregivers related to biosimilars.
The course will utilize a modular approach to provide content that is accessible and informative to all learners, and provide an introduction to biosimilar medications including what they are, regulatory processes, access, and discussing biosimilars with your healthcare provider.
This is an online self-directed course. There are no instructor-led activities.
Image
Kathy Vu
Instructor
More News
Image
McKesson Canada receives Corporate Partnership Award from Leslie Dan Faculty of Pharmacy
McKesson Canada has been recognized for its longstanding support of student awards, research and academic initiatives.
Read More
Image
GreenShield receives Corporate Partnership Service Award from Leslie Dan Faculty of Pharmacy
GreenShield has been recognized for its longstanding support of student training, experiential learning and research.
Read More
Image
Minister of Health announces pharmacist care expansion in Ontario during visit to Leslie Dan Faculty of Pharmacy
New measures will enable pharmacists to deliver more vaccines and treat additional common ailments, improving access to care across Ontario.
Read More